Inotrem announces the publication of its Phase IIa clinical study for nangibotide in the treatment of septic shock in peer review journal “Intensive Care Medicine”
June 2, 2020
Intensive Care Medicine publishes the results of Inotrem’s study which demonstrated the safety and tolerability of its lead compound, nangibotide, in patients suffering from septic